Testosterone Cream Medication Monograph

Testosterone is both a medication and steroid naturally found in the body. It is used to treat male hypogonadism but it can also be used off-label to treat females. It is a controlled substance because it can be abused to increase athletic ability. It is mainly produced by the testes in males. Due to feedback on the body, testosterone administration can cause the body to stop making its own testosterone, therefore therapy should be monitored closely by a physician

Indications: Testosterone is used to treat male hypogonadism

Indications (off-label): Testosterone is used to treat low libido or sexual dysfunction in women

Renal Dosing:There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied) Severe renal impairment: Use is contraindicated

Hepatic Impairment: There are no dosage adjustments provided in the manufacturer’s labeling Severe hepatic impairment: Use is contraindicated

Contraindications:breast cancer; prostate cancer (known or suspected); pregnant women or women who may become pregnant, breast-feeding women, hypersensitivity to testosterone; serious cardiac, hepatic, or renal disease

Warnings/Precautions:

Breast cancer: Long term use (>10 years) of parenteral testosterone for male hypogonadism may increase the risk of male breast cancer (Medras 2006)

Cardiovascular events: Available studies are inconclusive regarding the risk of developing major adverse cardiovascular events (MACE) such as nonfatal MI, stroke, or cardiovascular death following testosterone use. According to the FDA, prescribe testosterone therapy only for men with low testosterone levels caused by certain medical conditions (eg, disorders of the testicles, pituitary gland, brain) and confirmed by laboratory tests (FDA Drug Safety Communication 2015). The Endocrine Society suggests it may be prudent to avoid testosterone therapy in men who have experienced a cardiovascular event (eg, MI, stroke, acute coronary syndrome) in the past six months (The Endocrine Society 2014). Evaluate patients for cardiovascular risk factors prior to initiating therapy and monitor closely during therapy for cardiovascular events

Dyslipidemia: May alter serum lipid profile; use caution with history of MI or coronary artery disease

Gynecomastia: May cause gynecomastia, which may persist in patients treated for hypogonadism

Hepatic effects: Prolonged use of high doses of androgens has been associated with serious hepatic effects (peliosis hepatis, hepatic neoplasms, cholestatic hepatitis, jaundice). Discontinue therapy if signs or symptoms of hepatic dysfunction (such as jaundice) develop

Hypercalcemia: May cause hypercalcemia in patients with prolonged immobilization or cancer

Oligospermia: Large doses may suppress spermatogenesis; oligospermia may occur. Discontinue therapy if this occurs, if restarted, a lower dose should be used

Polycythemia: May increase hematocrit requiring dose adjustment or discontinuation. Withhold initial treatment in patients with hematocrit >50%. Discontinue therapy if hematocrit exceeds 54%; may reinitiate at lower dose

Priapism: Priapism or excessive sexual stimulation may occur; discontinue therapy if this occurs, if restarted, a lower dose should be used

Prostate cancer: May increase the risk of prostate cancer. Withhold therapy pending urological evaluation in patients with palpable prostate nodule or induration, PSA >4 ng/mL, or PSA >3 ng/mL in men at high risk of prostate cancer

Venous thromboembolism: Venous thromboembolic events, including deep vein thrombosis (DVT) and pulmonary embolism (PE), have been reported with testosterone products. Evaluate patients with symptoms of pain, edema, warmth, and erythema in the lower extremity for DVT and those with acute shortness of breath for PE. Discontinue therapy if a venous thromboembolism is suspected

Drug Interactions: Androgens may enhance the hypoglycemic effect of Blood Glucose Lowering Agents. Androgens may increase the serum concentration of cyclosporine (Systemic). Androgens may enhance the anticoagulant effect of Vitamin K Antagonists. Substrate of CYP2B6 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP3A4 (minor)

Please speak with your doctor or pharmacist about other possible drug interactions as this list is not all-inclusive

Adverse Reactions: Acne, enlarged breasts, increase in blood pressure, impaired fertility, skin irritation where injected, increased prostate size (BPH), mood disturbances

Storage: Room temperature

Patient Education:

What should I tell my doctor about before taking this medication?

Prostate problems or problems with urinating, prostate or breast cancer, liver problems, kidney problems, high cholesterol, history of or current heart problems, history of blood clots, fertility problems, other medications you take including those that are over-the-counter

What side effects should I call my doctor about right away?

Signs of an allergic reaction like rash, hives, or itching; signs of high blood pressure like severe headache, passing out, or dizziness; trouble passing urine passing urine more often, or a weak stream of urine; mood changes or depression; signs of a blood clot such as pain, swelling, warmth, or numbness in your arm or leg, confusion, extreme headache, weakness on one side; change in shape or size of testicles

When and how do I use this medication?

Testosterone cream should be applied at the same time each day to clean, dry, intact skin to an area of the body that can be covered by clothing. Avoid swimming, sweating, showering, or washing the application site for 2+ hours following application

Testosterone may be transferred to another person following skin-to-skin contact with the application site. Thoroughly wash hands after application and cover application site with clothing once cream has dried

In addition to skin-to-skin contact, secondary exposure has also been reported following exposure to secondary items (IE: towel, clothing, sheets). If secondary exposure occurs, the other person should thoroughly wash the skin with soap and water as soon as possible